Related by context. All words. (Click for frequent words.) 62 interrater reliability 61 HAMD 61 Montgomery Åsberg Depression 61 Edinburgh Postnatal Depression 61 BPRS 61 Y BOCS 60 psychometric properties 60 symptom checklist 60 EQ 5D 60 Brief Psychiatric 59 symptom severity 59 Global Impression CGI 59 Geriatric Depression 59 HAM D 59 BMI z 59 PANSS 59 depressive symptom 59 Distress Scale 59 YMRS 59 State Examination MMSE 59 Scale PANSS 58 Symptom Checklist 58 NIH CPSI 58 HADS 58 Hamilton Rating Scale 58 HAM D# 58 point Likert scale 58 retest reliability 58 randomized controlled trials RCTs 58 pretest probability 58 QIDS SR 58 Likert scale 58 Stroke Scale 58 Rating Scale MADRS 58 erection hardness 58 MMSE 57 multivariate regression analysis 57 MDQ 57 EPDS 57 CHADS2 57 HRQoL 57 conditional logistic regression 57 subscales 57 SF #v# 57 logistic regression analysis 57 APACHE II 57 ADAS Cog 57 Glasgow Coma Scale 56 Symptom severity 56 Status Scale EDSS 56 Neuropsychiatric Inventory NPI 56 subthreshold depression 56 hemoglobin A1c levels 56 PANSS total 56 Likert 56 CORE OM 56 DLQI 56 Reynolds Risk Score 56 biopsy Gleason 56 interpersonal psychotherapy 56 Negative Syndrome 56 posttest 56 Seattle Angina Questionnaire 56 Depression Scale 56 ARB telmisartan 56 meta analytic 56 Multiple logistic regression 56 HRQL 56 Depression Rating Scale 56 multivariate analyzes 56 convergent validity 56 comorbid depression 56 multiple linear regression 55 Visual Analogue Scale VAS 55 STEP BD 55 Liver biopsy 55 genomewide 55 HRQOL 55 Depressive symptoms 55 Neuropsychiatric Inventory 55 Vectra DA 55 QoL 55 Montgomery Asberg Depression 55 meta regression 55 Child Behavior Checklist 55 DAS# scores 55 Epworth Sleepiness Scale 55 Psychometric tests 55 adenoma recurrence 55 stratifying patients 55 KCCQ 55 ADAS cog 55 Rating Scale BPRS 55 Maslach Burnout Inventory 55 SSRI citalopram 55 Brief Pain 55 diabetes mellitus DM 55 Hopkins Symptom Checklist 55 Clinician Administered PTSD 55 ADCS CGIC 55 diagnosing ADHD 55 Kruskal Wallis test 55 MoxDuo TM IR 55 prevalences 55 non affective psychosis 55 Health Questionnaire PHQ 54 euthymic patients 54 Index CDAI 54 subscore 54 #F FDG PET 54 virological response 54 MMSE score 54 logistic regression 54 logistic regression models 54 CFQ R 54 State Exam MMSE 54 non menstrual pelvic 54 exhaled nitric oxide 54 conventional cytology 54 Bonferroni correction 54 oral anticoagulation 54 Stroke Scale NIHSS 54 somatoform disorders 54 multivariate Cox 54 Poisson regression 54 somatic symptoms 54 Health Assessment Questionnaire 54 binary logistic regression 54 psychodynamic psychotherapy 54 coronary artery calcium 54 Mania Rating Scale 54 MADRS 54 Pfizer reanalyzed 54 WAIS III 54 NHAMCS 54 perfusion CT 54 antiepileptics 54 IIEF 54 NYHA functional class 54 predictive validity 54 eNO 54 prospective longitudinal 54 trials RCTs 54 empirically validated 54 MMSE scores 54 extracolonic findings 54 logistic regression analyzes 54 unpaired t 54 episodic migraine 54 multivariable analysis 54 MADRS score 54 depressive symptomatology 54 antibiotic prophylaxis 54 multiple logistic regression 53 Cronbach alpha 53 multivariate logistic regression 53 interobserver 53 subclinical atherosclerosis 53 Inventory BPI 53 Beck Anxiety Inventory 53 clomipramine 53 FDG PET 53 albumin excretion 53 WOMAC pain 53 PSQI 53 Pain Rating Scale 53 oncologic outcomes 53 interobserver reliability 53 Coronary artery calcium 53 tuberculin skin test 53 SYNTAX 53 Crohn Disease Activity 53 OGTT 53 Cystic Fibrosis Questionnaire Revised 53 HOMA IR 53 SELENA SLEDAI 53 Outcomes Study 53 abnormal cytology 53 PROLARIS 53 Visual Analog 53 variance ANOVA 53 diagnostic modality 53 semistructured interview 53 interrater 53 diagnosing coronary artery 53 dose Iluvien 53 subsyndromal 53 Negative Symptoms 53 guideline concordant 53 FDG-PET/CT 53 subscores 53 NIHSS 53 colonoscopic 53 hemoglobin A1C 53 procalcitonin 53 Fibromyalgia Impact Questionnaire 53 nasal symptom 53 ANOVA 53 intraclass correlation coefficients 53 Epidemiological Studies Depression 53 serum ferritin 53 hypochondriasis 53 postoperative complication 53 estimated GFR 52 RCTs 52 EORTC QLQ C# 52 eC SSRS 52 syndromal 52 overnight polysomnography 52 DSM IV diagnoses 52 thyroglobulin 52 intraobserver 52 EDSS score 52 nonpharmacologic 52 reboxetine 52 semistructured 52 attain statistical significance 52 Skin sterol 52 TMS Therapy 52 antidepressant therapy 52 DAS# CRP 52 Visual Analogue Scale 52 psychiatric outpatients 52 CIN2 + 52 Subgroup analyzes 52 Functional Assessment 52 SGAs 52 liver biopsies 52 DAS# [002] 52 CAHPS 52 retrospective observational study 52 Kaplan Meier analysis 52 Rating Scale IRLS 52 PERMP 52 NSQIP 52 QRISK 52 Mini Mental 52 protease inhibitor PI 52 preoperative diagnosis 52 Ocular Surface Disease 52 lipid lowering therapy 52 semistructured interviews 52 adenotonsillectomy 52 Logistic regression 52 hemoglobin A1c HbA1c 52 psychiatric comorbidity 52 INVEGA ® 52 Depression Inventory 52 Interrater reliability 52 CNS LS 52 COR Analyzer 52 WOMAC 52 subtests 52 Preoperatively 52 metaanalysis 52 logistic regression model 52 DQI 52 FDG PET scans 52 Alzheimer Disease Assessment 52 nondepressed 52 careHPV 52 multivariate regression 52 retrospective cohort 52 microalbumin 52 thiopurine 52 depressive symptoms 52 IQR 52 Score DAS# 52 CAARS 52 Recurrence Score 52 Cardiorespiratory fitness 52 gauge vitrectomy 52 DEXA scans 52 Cardiotoxicity 52 HbA1C 52 Hemoccult II 52 hematopoietic cancers 52 Scale EDSS 52 BI RADS 52 Framingham Risk Score 52 subscale scores 52 prognostic variables 52 intelligence quotient IQ 52 univariate analyzes 52 multivariable logistic regression 52 aldosterone antagonist 52 International Prognostic Scoring 52 NIHSS score 52 HbA 1c levels 51 tumor histology 51 serologic testing 51 transient elastography 51 endometrial biopsy 51 divalproex sodium 51 CHADS 51 exploratory endpoints 51 Rating Scale 51 Depression Inventory BDI 51 Treatment Diabetic Retinopathy 51 antibody titer 51 inhaled corticosteroid therapy 51 Multiple linear regression 51 PD2i ® 51 perimenopausal women 51 Perceived Stress Scale 51 formative assessments 51 spirometric 51 multivariable Cox 51 stepwise logistic regression 51 comorbidity 51 Questionnaire 51 bivariate analyzes 51 urine cytology 51 coronary calcium 51 HCAHPS 51 CIN3 51 Numeric Rating Scale 51 F FDG PET 51 comorbid diagnoses 51 FeNO 51 Hemoglobin A1c 51 IGRAs 51 psychiatric comorbidities 51 actigraphy 51 comorbid psychiatric disorders 51 teriflunomide 51 chronic prostatitis chronic 51 glycated hemoglobin levels 51 BENICAR HCT 51 warfarin dose 51 NNT = 51 catheter angiography 51 CHADS 2 51 dysthymia 51 sputum specimens 51 Pearson correlation coefficient 51 warfarin dosage 51 genotypic resistance 51 IPSS 51 Cognitive Behavioural Therapy 51 function subscale 51 HAQ DI 51 UPDRS motor 51 diagnosing autism 51 preoperatively 51 Neuropsychological Status 51 silent myocardial ischemia 51 albumin excretion rate 51 posttreatment 51 Cognitive Abilities Test 51 comorbid anxiety 51 cytologic 51 methotrexate monotherapy 51 Abnormal Involuntary Movement 51 chest radiographs 51 CaPSURE 51 citalopram 51 Epidemiologic Studies Depression 51 bulimia nervosa 51 Severity Index PASI 51 urine albumin 51 smoldering multiple myeloma 51 HDRS 51 Meta analyzes 51 differentiate squamous 51 colorectal adenoma 51 biologic DMARDs 51 Regression analyzes 51 WISC IV 51 Hamilton Anxiety Scale 51 serum cotinine 51 Scale Cognitive Subscale 51 T2DM 51 PISA exam 51 A1c levels 51 System IPSS 51 CT perfusion 51 generalized estimating 51 glycated hemoglobin 51 concomitant medications 51 Charlson Comorbidity Index 51 neurocognitive function 51 cognitive affective 51 randomized controlled trials 51 Generalized Anxiety Disorder 51 DEXA scan 51 TAXUS ARRIVE 51 salivary cortisol 51 MetS 51 HEDIS R 51 Functioning GAF 51 CLBP 51 Sentinel Lymph Node Biopsy 51 chlamydial infection 51 psychoeducation 51 Secondary efficacy endpoints 51 GWTG 50 stepwise regression 50 Structured Clinical 50 risperidone Risperdal 50 Interpersonal psychotherapy 50 #.#ng/ml 50 ImmuKnow 50 extensive metabolizers 50 APGAR 50 PEPI 50 bivariate 50 psychosocial functioning 50 Zevalin consolidation 50 atypical antipsychotic medications 50 pharmacological therapy 50 nonpharmacologic interventions 50 liver biopsy 50 orofacial pain 50 hepatitis C genotype 50 Depressive Symptomatology 50 hypertensives 50 overt hypothyroidism 50 Wechsler Intelligence 50 sensitivity specificity 50 coronary stenosis 50 randomized multicenter trial 50 rhinoconjunctivitis 50 Multivariate analysis 50 BILAG 50 biochemical recurrence 50 undetectable HBV DNA 50 Functional Capacity 50 VTE prophylaxis 50 glycosylated hemoglobin levels 50 Comorbidity 50 digital rectal examination 50 EUS FNA 50 interpersonal psychotherapy IPT 50 desvenlafaxine succinate 50 AIMSweb 50 N acetylcysteine 50 HoLEP 50 relapsed MM 50 bivariate analysis 50 multivariable regression 50 chronic rhinosinusitis CRS 50 sleeve lobectomy 50 psychiatric diagnoses 50 multivariate statistical 50 emotional lability 50 AHEI 50 AMOR IPAT 50 GH deficiency 50 Comorbidities 50 ITBS 50 SSRI SNRI 50 nationally normed test 50 antihypertensive therapy 50 Mantoux skin 50 PLMS 50 cTnT levels 50 mammographic density 50 QOL questionnaire 50 Common Terminology Criteria 50 D dimer 50 transcranial Doppler ultrasound 50 carotid stenosis 50 aldosterone antagonists 50 polyp recurrence 50 psychometric 50 Wechsler Adult 50 cystoscopic 50 virologic response 50 MSLT 50 baseline HbA1c 50 inotropic 50 hydroxyvitamin D levels 50 HEDIS 50 UPDRS 50 abdominal adiposity 50 FDG PET imaging 50 BODE index 50 Yearly ProgressPro 50 neoadjuvant treatment 50 C SSRS 50 Relieve Depression 50 hsCRP 50 univariate 50 ANCOVA 50 urine dipstick 50 RISPERDAL ® 50 microsatellite instability 50 Multivariate logistic regression 50 nonadherence 50 euthymic 50 venous thromboembolism prophylaxis 50 suicide attempters 50 conventional angiography 50 NeuroStar TMS Therapy 50 diagnose appendicitis 50 noncognitive 50 virologically 50 Valdoxan 50 Oral NKTR 50 coronary CTA 50 hepatic lesions 50 endoscopic gastric ulcers 50 MDCT angiography 50 Perforomist Inhalation Solution 50 urodynamic 50 plain radiographs 50 Descriptive statistics 50 sertraline 50 hemoglobin A1c 50 PSADT 50 AGHD 50 intensive statin therapy 50 antidiabetic medication 50 IBDQ 50 Pearson correlation coefficients 50 Visual Analog Scale 50 clinical meaningfulness 50 fructosamine 50 Erectile Function 50 endometrial thickness 50 rEEG 50 sociodemographic characteristics 50 paliperidone ER 50 PSA nadir 50 psychotherapeutic interventions 50 Female Sexual Function 50 serum PSA 50 elevated ALT 50 periprosthetic infection 50 SRBD 50 oral glucose tolerance 50 CT angiograms 50 Paroxetine 50 compulsive hoarding syndrome 50 bronchial hyperresponsiveness 50 FENO 50 Cronbach 50 advanced neoplasia 50 empirically derived 50 comorbid disorders 50 colorectal liver metastases 50 covariate 50 Methods Retrospective 50 transrectal ultrasound guided 50 Wilcoxon rank sum 50 SMBG 50 acetabular fractures 50 CONCERTA ® 50 Diagnostic Interview 50 BMD measurements 50 elevated CRP 50 DIBELS 50 cirrhotic patients 50 nomogram 50 clinically meaningful improvement 50 corticosteroid dose 49 pyridostigmine 49 symptomatic VTE 49 MTWA testing 49 LTRAs 49 MS DRG 49 SDQ 49 posttransplant 49 preoperative PSA 49 body habitus 49 Endothelial function 49 Sociodemographic 49 fluorodeoxyglucose positron emission tomography 49 prospective observational cohort 49 neuropsychological assessment 49 MELD 49 chi squared 49 ratio WHR 49 prazosin 49 nonpsychotic 49 serum cortisol 49 endoscopist 49 comorbid 49 histopathologic 49 transvaginal sonography 49 SLNB 49 histologically proven 49 generalized epilepsy 49 BEXXAR Therapeutic Regimen 49 observable behaviors 49 antenatal depression 49 odds ratios ORs 49 Immunohistochemistry 49 premorbid 49 semiquantitative 49 generalisable 49 analgesic medications 49 hsCRP levels 49 mg BID dose 49 ACS NSQIP 49 clinico pathological 49 HbA 1C 49 liver histology 49 ROC curves 49 affective psychosis 49 psychometrically sound 49 prospective multicenter study 49 Incontinence Impact Questionnaire 49 p = .# [002] 49 LUTS 49 diagnosing bipolar disorder 49 somatization 49 myocardial viability 49 paroxysmal AF 49 BRCA testing 49 pelvic lymphadenectomy 49 glycated hemoglobin HbA1c 49 ETDRS 49 NSTE ACS 49 Quotient TM 49 DXA 49 radiographic outcomes 49 VADT 49 CPAP adherence 49 Clinical Psychiatry 49 CI -#.# 49 Oncotype 49 suicide ideation 49 urodynamic parameters 49 urinary symptoms 49 CIBIC plus 49 intraclass correlation coefficient 49 antibiotic regimens 49 mammographically 49 transabdominal 49 glycosylated hemoglobin HbA1c 49 postprocedure 49 schizophrenia schizoaffective disorder 49 NSTEMI 49 demonstrated clinically meaningful 49 PD2i R 49 HbA1c levels 49 HIV tropism 49 DSM IV diagnosis 49 IRLS score 49 statistically significant correlation 49 placebo controlled trials 49 histological subtype 49 scintigraphic 49 macroalbuminuria 49 coronary CT angiography 49 ADHD RS 49 Pharmacoeconomic 49 Stanford Binet 49 SIMPADICO 49 virtual colonography 49 Abilify aripiprazole 49 postexposure prophylaxis 49 diagnostically 49 internalizing behaviors 49 alexithymia 49 sertraline Zoloft 49 overactive bladder symptoms 49 RE LY 49 proton MR spectroscopy 49 Glomerular filtration rate 49 serum urate levels 49 randomized controlled trial 49 perimetry 49 Vasotrac 49 Likert type 49 serum clusterin levels 49 waist circumference WC 49 colorectal neoplasia 49 polyp detection 49 discriminant 49 BYSTOLIC 49 observational cohort study 49 UKPDS 49 obstructive CAD 49 Rating Scale UPDRS 49 Schema Therapy 49 TNM staging 49 intima media thickness 49 pretreatment serum 49 PASI scores 49 Subscale 49 endoscopists 49 Injury Severity Score 49 carotid IMT 49 APOE genotype 49 neurocognitive functioning 49 International Prostate Symptom 49 Charlson comorbidity index 49 alteplase 49 pre operatively 49 lipid abnormalities 49 APOE e4 49 Expanded Disability Status 49 patient subpopulations 49 Primary endpoints 49 MDRD equation 49 HpSA 49 Suicidal ideation 49 QoF 49 Histologic 49 Antidepressant Medication 49 prospectively randomized 49 conjoint analysis 49 psychometrically 49 droperidol 49 Prostate Specific Antigen PSA 49 ELISPOT 49 GPRD 49 pain subscale 49 correlation coefficients 49 haematologic 49 Logistic regression analysis 49 BRFSS 49 syndromic 49 duplex ultrasonography 49 catheter ablations 49 Index FSFI 49 immunohistochemical 49 Psychosomatic Research 49 Framingham Offspring 49 Appropriateness Criteria 49 Tumor Response 49 Haptoglobin 49 DSM IV Axis 49 carotid ultrasound 49 co receptor tropism 49 MSCT 49 NicAlert TM 49 pCR 49 nationally normed 49 FRAX 49 miRview squamous 49 poor metabolizers 49 TOEIC tests 49 SGRQ 49 psychopharmacological 49 immunochemical 49 postoperative pulmonary 49 HER2 overexpression 49 prognostic indicators 49 CARDIA 49 generalized anxiety disorder 49 Clinical Practice Guideline 49 EarlyCDT Lung 49 PITX2 methylation 49 atypical neuroleptics 49 initiating antiretroviral therapy 49 FDG PET CT 49 cinacalcet 49 Interpersonal Psychotherapy 49 dyspnoea 49 unipolar depression 49 Piotroski 49 STRIDE PD 49 immunochemical fecal occult 49 Bonferroni 49 MDRD 49 paricalcitol 49 Acute Physiology 49 Heritability 49 Polysomnography 49 Likert pain 49 pregabalin 49 prospectively enrolled 49 Lexile measure 49 serum lipid levels 49 Screening Trial DMIST 49 VerifyNow 49 DCCT 49 Hemoccult 49 antipsychotic prescribing 49 hormone receptor negative 49 QRS duration 49 multivariable adjusted 49 primary aldosteronism 49 ICD implantation 49 topical NSAIDs 49 percutaneous vertebroplasty 49 thromboprophylaxis 49 Lexile 49 paroxetine Paxil 49 Ishak fibrosis score 48 limiting generalizability 48 Coronary CTA 48 Psoriasis Area 48 ICD therapy 48 autistic traits 48 stratify patients 48 pharmacogenetic testing 48 Neurocognitive 48 somatic complaints 48 summative evaluation 48 adalimumab 48 Pharmacotherapy 48 metabolic syndrome MetS 48 NAMCS 48 tic disorders 48 aPTT 48 glomerular filtration 48 SDAA II 48 VCUG 48 criterion referenced 48 prodromal symptoms 48 blood Phe levels 48 Analytical Reasoning 48 reflux symptoms 48 transdermal testosterone 48 IRLS 48 nonvertebral fracture 48 precancer 48 Medication adherence 48 inflammatory biomarkers 48 Prostate specific antigen 48 pentoxifylline 48 nulliparous women 48 RECIST criteria 48 ACI TIPI 48 TVAAS 48 susceptibility loci 48 nonfasting 48 nuchal translucency 48 serotonin reuptake inhibitor 48 platelet reactivity 48 anagrelide 48 dietary questionnaires 48 NPRS 48 analgesic efficacy 48 nonparametric 48 IV bisphosphonates 48 Quantitative EEG 48 secondary efficacy endpoint 48 tryptophan depletion 48 urinary albumin excretion 48 solifenacin 48 Pain Intensity 48 anti JCV antibodies 48 chronic periodontitis 48 observable characteristics 48 QEEG 48 prostate cancer PCa 48 Score IPSS 48 regression coefficient 48 Common Toxicity Criteria 48 HbA 1c 48 Hb A1C 48 summative 48 tertile 48 PreDx DRS 48 oral antidiabetes drugs 48 DXA scans 48 Functioning Scale 48 RAPAFLO R 48 affective disorders 48 donepezil Aricept 48 #q# deletion syndrome 48 Cognitive behavioral 48 CDAI 48 colon capsule endoscopy 48 GERD symptom 48 Follicular Lymphoma 48 chromium picolinate supplementation 48 coronary artery calcification 48 serum thyroglobulin 48 Main Outcome Measure 48 ADHD Rating Scale 48 serological tests 48 LV dysfunction 48 Depression Scale HADS 48 Screening Tool 48 tipranavir ritonavir 48 Flesch Kincaid 48 Wechsler Memory 48 GAMMAGARD 48 multivariable analyzes 48 ERCP 48 nomograms 48 Szeinbach 48 preoperative chemotherapy 48 guaiac 48 aromatase inhibitor therapy 48 urolithiasis 48 PAP smear 48 subtest 48 URTI 48 Literacy Skills DIBELS 48 endoscopic retrograde cholangiopancreatography ERCGrant Parpan 48 Raven Progressive Matrices 48 GYTS 48 CP CPPS 48 Kruskal Wallis 48 generalizability 48 EasyCD4 48 spiral computed tomography 48 dose atorvastatin 48 timepoints 48 neuropsychological assessments 48 CT colonography 48 NAEP math 48 Apgar scores 48 Randomized trials 48 PCA3 scores 48 QualityMetric 48 postoperative mortality 48 nonmetastatic 48 antihypertensive agents 48 PSA kinetics 48 Viral load 48 #F FDG 48 nonmetastatic prostate cancer 48 Disease Activity 48 salmeterol fluticasone 48 upper endoscopy 48 pharmacologic treatments 48 MammaPrint R 48 Computed tomographic 48 darunavir ritonavir 48 Mantel Haenszel 48 attention-deficit/hyperactivity disorder ADHD 48 moderate renal impairment 48 Oncotype DX Recurrence Score 48 nonsevere 48 stratifies 48 retrospective cohort study 48 V3D Colon 48 bi ventricular pacing 48 Systematic Treatment 48 venlafaxine XR 48 cortical atrophy 48 Repeatable Battery 48 Ashworth Scale 48 psychopathological symptoms 48 beta blocker therapy 48 multigene expression test 48 postintervention 48 adjuvant therapies 48 Intervention Trial 48 antioxidant supplementation 48 carotid artery narrowing 48 OncotypeDX 48 clevidipine 48 KOOS 48 FACIT 48 intratympanic 48 antitumor effect 48 generalisability 48 HAART initiation 48 Getzenberg 48 intermittent dosing 48 longitudinal cohort study 48 RECIST Response Evaluation Criteria 48 Renal Cell Carcinoma RCC 48 methodologically sound 48 Urogenital Distress Inventory 48 perinatal outcomes 48 lymphocyte count 48 pharmacologic therapy 48 olanzapine LAI 48 sonographic diagnosis 48 SLN biopsy 48 subclinical disease 48 neurodevelopmental outcome 48 thyrotropin levels 48 pT2 48 cognitive behavioral therapies 48 deCODE BreastCancer TM 48 HORIZONS AMI trial 48 tipranavir r 48 antiarrhythmic drug 48 cognitive behavioral therapy 48 Symptom Severity 48 axillary lymph node 48 meta analysis 48 protease inhibitor mutations 48 visceral adiposity 48 hypomanic symptoms 48 Balloon sinuplasty 48 resected pancreatic cancer 48 screening colonoscopy 48 Major Depressive Disorder 48 escitalopram 48 advanced adenomas 48 StO2 48 Visual acuity 48 ECLS 48 lidocaine gel 48 psychotherapies 48 ad hoc querying 48 completely resected 48 Univariate analysis 48 behavioral disinhibition 48 meta analytic review 48 hypofractionated radiation 48 erythrocyte sedimentation rate 48 chemoprevention trials 48 induced sputum 48 colposcopic 48 prospective nonrandomized